Zarema Albakova

Ms. Zarema Albakova

Moscow State University
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Cells
Verified
Journal Article
Open access
PDF file
ZAZarema Albakova
Zarema Albakova
GAGrigoriy Armeev
Grigoriy Armeev
LKLeonid M. Kanevskiy
Leonid M. Kanevskiy
EKElena Kovalenko
Elena Kovalenko
ASAlexander Sapozhnikov
Alexander Sapozhnikov
The 70-kDa heat shock proteins (HSP70s) are abundantly present in cancer, providing malignant cells selective advantage by suppressing multiple apoptotic pathways, regulating necrosis, bypassing cellular senescence program, interfering with tumor immunity, promoting angiogenesis and supporting metastasis. This direct involvement of HSP70 in most of the cancer hallmarks explains the phenomenon of cancer “addiction” to HSP70, tightly linking tumor survival and growth to the HSP70 expression. HSP70 operates in different states through its catalytic cycle, suggesting that it can multi-function in malignant cells in any of these states. Clinically, tumor cells intensively release HSP70 in extracellular microenvironment, resulting in diverse outcomes for patient survival. Given its clinical significance, small molecule inhibitors were developed to target different sites of the HSP70 machinery. Furthermore, several HSP70-based immunotherapy approaches were assessed in clinical trials. This review will explore different roles of HSP70 on cancer progression and emphasize the importance of understanding the flexibility of HSP70 nature for future development of anti-cancer therapies.

1 February 2021 in Translational Oncology
Verified
Journal Article
Open access
ZAZarema Albakova
Zarema Albakova
MSMohammad Kawsar Sharif Siam
Mohammad Kawsar Sharif Siam
PSPradeep Kumar Sacitharan
Pradeep Kumar Sacitharan
RZRustam H. Ziganshin
Rustam H. Ziganshin
DRDmitriy Y. Ryazantsev
Dmitriy Y. Ryazantsev
ASAlexander M. Sapozhnikov
Alexander M. Sapozhnikov
• High expression of extracellular heat shock proteins (HSPs) indicates highly aggressive tumors. • HSP profiling of extracellular vesicles (EVs) derived from various biological fluids and released by immune cells may open new perspectives for an identification of diagnostic, prognostic and predictive biomarkers of cancer. • Identification of specific microRNAs targeting HSPs in EVs may be a promising strategy for the discovery of novel biomarkers of cancer.

21 January 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
ZAZarema Albakova
Zarema Albakova
YMYana Mangasarova
Yana Mangasarova
AAAkhmet Albakov
Akhmet Albakov
LGLiliya Gorenkova
Liliya Gorenkova
HSP70 and HSP90 are two powerful chaperone machineries involved in survival and proliferation of tumor cells. Residing in various cellular compartments, HSP70 and HSP90 perform specific functions. Concurrently, HSP70 and HSP90 homologs may also translocate from their primary site under various stress conditions. Herein, we address the current literature on the role of HSP70 and HSP90 chaperone networks in cancer. The goal is to provide a comprehensive review on the functions of cytosolic, mitochondrial and endoplasmic reticulum HSP70 and HSP90 homologs in cancer. Given that high expression of HSP70 and HSP90 enhances tumor development and associates with tumor aggressiveness, further understanding of HSP70 and HSP90 chaperone networks may provide clues for the discoveries of novel anti-cancer therapies.

1 August 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ZAZarema Albakova
Zarema Albakova
The 90-kDa heat shock proteins (HSP90s) are molecular chaperones essential for folding, unfolding, degradation and activity of a wide range of client proteins. HSP90s and their cognate co-chaperones are subject to various post-translational modifications, functional consequences of which are not fully understood in cancer. Intracellular and extracellular HSP90 family members (HSP90α, HSP90β, GRP94 and TRAP1) promote cancer by sustaining various hallmarks of cancer, including cell death resistance, replicative immortality, tumor immunity, angiogenesis, invasion and metastasis. Given the importance of HSP90 in tumor progression, various inhibitors and HSP90-based vaccines were developed for the treatment of cancer. Further understanding of HSP90 functions in cancer may provide new opportunities and novel therapeutic strategies for the treatment of cancer.

30 November 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
ZAZarema Albakova
Zarema Albakova
YMYana Mangasarova
Yana Mangasarova
Heat shock proteins are molecular chaperones which support tumor development by regulating various cellular processes including unfolded protein response, mitochondrial bioenergetics, apoptosis, autophagy, necroptosis, lipid metabolism, angiogenesis, cancer cell stemness, epithelial-mesenchymal transition and tumor immunity. Apart from their intracellular activities, HSPs have also distinct extracellular functions. However, the role that HSP chaperones play in the regulation of immune responses inside and outside the cell is not yet clear. Herein, we explore the intracellular and extracellular immunologic functions of HSPs in cancer. A broader understanding of how HSPs modulate immune responses may provide critical insights for the development of effective immunotherapies.

1 January 2021 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
MSMarina Shevchenko
Marina Shevchenko
ESEkaterina Servuli
Ekaterina Servuli
ZAZarema Albakova
Zarema Albakova
LKLeonid Kanevskiy
Leonid Kanevskiy
ASAlexander Sapozhnikov
Alexander Sapozhnikov
Asthma is a complex chronic disorder of the airways, affecting immune and structural cells and inducing both protein and tissue remodeling. Heat shock proteins 70 kDa (HSP70s) are highly conserved members of the stress-induced family, possessing precisely described chaperone activity. There is growing evidence of a tight relationship between inflammatory diseases of different origins and the elevation of local HSP70 expression and secretion. Although extracellular HSP70 does not serve as a common marker of asthma, elevated HSP70 levels have been detected in the peripheral blood serum and sputum of patients with asthma, as well as in the bronchoalveolar lavage fluid of mice with induced allergic airway inflammation. Possessing diverse immunomodulating properties, extracellular HSP70 can manifest different activities in airway inflammatory processes and asthma, acting either as a pro-inflammatory trigger, or an anti-inflammatory agent. This review will discuss the effects and possible mechanisms concerning HSP70 implication in airway inflammation regulation in asthma. We examine ATPase and chaperone activities of HSP70 as potential modulators of immune responses in asthma. Given the crucial role of a chronic inflammatory response in asthma, understanding the effects of HSP70 on immune and structural cells may reveal new perspectives for the therapeutic control of inflammation.